Petal Consortium

Jain Lab

About Us

Study Details

News Center

For Healthcare Professionals

Participating Centers

Support Us

Jain lab

Consortium Highlights & Events

February, 2025

We are excited to share that PETAL is launching a Phase III trial evaluating Soquelitinib versus Standard of Care in relapsed/refractory PTCL-NOS, FHTCLs, and sALCL, multicenter study that is aimed at advancing the treatment options for aggressive lymphomas.

An inspiring story shared by our PETAL patient on how Specialized Expertise Transformed a Critical Setback From Peripheral T-cell Lymphoma Into Hope

Blood Cancers Today spoke with researchers from the Salvia Jain Lab to learn more about the goals and initiatives of the PETAL Consortium. Leora Boussi, MD, Angela Koh, and Jessy Xinyi Han discuss their study of a novel scoring system using one of the largest international global cohorts of 925 patients with relapsed or refractory mature T-cell and NK-cell lymphomas.

PETAL has been prominently featured in the MGH Cancer Center Curtain Raiser and the Mass General Brigham Cancer Center newsletter, which reaches over 20,000 individuals across academia, industry, and other fields. We are excited to share key updates on our research with this wide audience.

We are pleased to share that the University of Pennsylvania (UPenn) is our third participating site which is now active for enrollment

PETAL goes LIVE on social media! As we ramp up our efforts, the PETAL Consortium is now active on Facebook, LinkedIn, Instagram, and Twitter. Follow us for regular updates, insightful resources, and exciting developments in T-cell lymphoma research. Let’s make science accessible and drive meaningful change together.

December, 2024

The PETAL team proudly participated in the ASH 2024 conference, showcasing our work through three poster presentations and an oral session. This opportunity highlighted PETAL’s innovative contributions to the field of hematology.

The PETAL Consortium held its second annual Investigators’ Meeting, highlighting significant study progress, sharing operational and regulatory updates, along with celebrating milestones, and outlining strategic goals for the future of the consortium.

November, 2024

The BROAD Institute joins PETAL as a genomics collaborator, bringing cutting-edge expertise to the consortium.

September, 2024

Mass General Cancer Center organized a 5k Run-Walk where the PETAL team along with the whole Cancer Center was running for a cause. Where we raised awareness and funds to support our research with the help, support and dedication of our patients, families and friends who joined us for a cause.

PETAL consortium’s second site Dana Farber Cancer Institute (DFCI) is successfully activated for enrollment

August, 2024

Daiichi Sankyo Inc. and Kyowa Kirin join as the key sponsors to advance the future research at PETAL consortium

July, 2024

Acrotech Biopharma joins PETAL, supporting the development of the consortium and personalized treatments for rare lymphomas.

June, 2024

PETAL Consortium @TCLF 2024 excited to share our work through many oral and poster presentations

Mark Sorial receives an educational grant from SecuraBio to develop novel machine learning models to estimate outcomes for patients with peripheral T-cell lymphoma.

February, 2024

PETAL Consortium’s first site Massachusetts General Hospital (MGH) is successfully activated for patient enrollment

December, 2023

The first PETAL Investigators meeting was held at ASH 2023 conference discussing the scope of PETAL and future of T-cell Lymphoma research.

Study details

Our Study

Flow Chart

Study Sypnosis

News center

Consortium Highlights & Events

Publications

Social Media

For healthcare professionals

PIRT Calculator

Participating Sites Login

Study details

Our Study

Flow Chart

Study Sypnosis

News center

Consortium Highlights & Events

Publications

Social Media

For healthcare professionals

PIRT Calculator

Participating Sites Login

Consortium Highlights & Events

Consortium Highlights & Events

Consortium Highlights & Events

February, 2025

January, 2025

December, 2024

November, 2024

September, 2024

August, 2024

July, 2024

June, 2024

May, 2024

February, 2024

December, 2023

Menu

Study details

News center

For healthcare professionals

Menu

Study details

News center

For healthcare professionals